Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;26(2):222-e17.
doi: 10.1111/ene.13773. Epub 2018 Sep 21.

Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease

Affiliations

Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease

H S Dafsari et al. Eur J Neurol. 2019 Feb.

Abstract

Background and purpose: Subthalamic nucleus (STN) deep brain stimulation (DBS) improves quality of life (QoL) and motor and non-motor symptoms in advanced Parkinson's disease (PD). However, its effect on alexithymia and its relationship to other neuropsychiatric symptoms and QoL in PD is unclear.

Methods: In this prospective, observational study of 39 patients with PD undergoing STN-DBS, we examined the Parkinson's Disease Questionnaire-8 (PDQ-8), 20-item Toronto Alexithymia Scale (TAS-20), Hospital Anxiety and Depression Scale (HADS), Self-Report Manic Inventory (SRMI), Apathy Evaluation Scale (AES), Unified Parkinson's Disease Rating Scale (UPDRS) activities of daily living, UPDRS motor examination and UPDRS complications (UPDRS-II/-III/-IV) and levodopa-equivalent daily dose (LEDD) pre-operatively and at 5-month follow-up. Outcome changes were tested with Wilcoxon signed-rank or paired t-test when parametric tests were applicable and corrected for multiple comparisons. The relationship between outcome changes was explored with bivariate correlations. Additionally, partial correlations between PDQ-8 and TAS-20 were computed controlling for HADS, SRMI and AES change scores. Predictor analyses for PDQ-8 improvement were calculated for all baseline parameters.

Results: The baseline prevalence of alexithymia was 17.9%. We observed significant beneficial effects of STN-DBS on PDQ-8, TAS-20, HADS, UPDRS-II, -III and -IV scores and significant LEDD reduction. The correlation between TAS-20 and PDQ-8 improvements remained significant after controlling for all other aforementioned outcomes. Predictor analyses for PDQ-8 improvement were significant for PDQ-8 and TAS-20.

Conclusions: This is the first report of beneficial effects of STN-DBS on alexithymia. Alexithymia was significantly associated with QoL outcome independent of anxiety, depression, mania and apathy. Our study highlights the importance of alexithymia for holistic assessments of DBS outcomes.

Keywords: 20-item Toronto Alexithymia Scale; apathy; deep brain stimulation; non-motor symptoms; quality of life.

PubMed Disclaimer

Similar articles

Cited by

  • Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
    Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. NPJ Parkinsons Dis. 2021 Jun 8;7(1):48. doi: 10.1038/s41531-021-00174-x. NPJ Parkinsons Dis. 2021. PMID: 34103534 Free PMC article.
  • Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.
    Sauerbier A, Loehrer P, Jost ST, Heil S, Petry-Schmelzer JN, Herberg J, Bachon P, Aloui S, Gronostay A, Klingelhoefer L, Baldermann JC, Huys D, Nimsky C, Barbe MT, Fink GR, Martinez-Martin P, Ray Chaudhuri K, Visser-Vandewalle V, Timmermann L, Weintraub D, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Sauerbier A, et al. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1313-1318. doi: 10.1136/jnnp-2021-326131. Epub 2021 Sep 11. J Neurol Neurosurg Psychiatry. 2021. PMID: 34510000 Free PMC article.
  • Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's Disease.
    Sauerbier A, Bachon P, Ambrosio L, Loehrer PA, Rizos A, Jost ST, Gronostay A, Fink GR, Ashkan K, Nimsky C, Visser-Vandewalle V, Chaudhuri KR, Timmermann L, Martinez-Martin P, Dafsari HS; EUROPAR, the Non-Motor Parkinson’s Disease Research Group and the German Parkinson Society Non-Motor Symptoms Study Group. Sauerbier A, et al. J Pers Med. 2024 Sep 26;14(10):1023. doi: 10.3390/jpm14101023. J Pers Med. 2024. PMID: 39452531 Free PMC article.
  • Possible Implications of Managing Alexithymia on Quality of Life in Parkinson's Disease: A Systematic Review.
    Culicetto L, Formica C, Lo Buono V, Latella D, Maresca G, Brigandì A, Sorbera C, Di Lorenzo G, Quartarone A, Marino S. Culicetto L, et al. Parkinsons Dis. 2024 Aug 27;2024:5551796. doi: 10.1155/2024/5551796. eCollection 2024. Parkinsons Dis. 2024. PMID: 39228428 Free PMC article. Review.
  • Gender gap in deep brain stimulation for Parkinson's disease.
    Jost ST, Strobel L, Rizos A, Loehrer PA, Ashkan K, Evans J, Rosenkranz F, Barbe MT, Fink GR, Franklin J, Sauerbier A, Nimsky C, Sattari A, Ray Chaudhuri K, Antonini A, Timmermann L, Martinez-Martin P, Silverdale M, Kalbe E, Visser-Vandewalle V, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. NPJ Parkinsons Dis. 2022 Apr 20;8(1):47. doi: 10.1038/s41531-022-00305-y. NPJ Parkinsons Dis. 2022. PMID: 35444187 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources